Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Johnson

Showing results (101-110 of 171) with videos related to

Pageof 18
Sort By:
Chemmedchem|April 11, 2022
Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor ChemotypeChristopher R M Asquith, Louisa Temme, Michael P East, et al.
Molecular & Cellular Proteomics : MCP|February 22, 2014
An unbiased proteomic screen reveals caspase cleavage is positively and negatively regulated by substrate phosphorylationJacob P Turowec, Stephanie A Zukowski, James D R Knight, et al.
Frontiers in Oncology|June 10, 2024
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of <i>PTEN</i>-null, <i>BRAFV600E</i> melanoma to BRAF/MEK inhibitionEvan DuBose, Samantha M Bevill, Dana K Mitchell, et al.
Cell Reports|March 9, 2017
MAP3K4 Controls the Chromatin Modifier HDAC6 during Trophoblast Stem Cell Epithelial-to-Mesenchymal TransitionRobert J Mobley, Deepthi Raghu, Lauren D Duke, et al.
British Journal of Pharmacology|October 5, 2017
Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysisBrian C Jensen, Traci L Parry, Wei Huang, et al.
The Biochemical Journal|November 21, 2007
Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complexHeidi Mendoza, David G Campbell, Kerry Burness, et al.
Journal of Medicinal Chemistry|April 12, 2019
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in ChordomaChristopher R M Asquith, Kaleb M Naegeli, Michael P East, et al.
Molecules (Basel, Switzerland)|October 13, 2021
Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid TumorsAndreas S Kalogirou, Michael P East, Tuomo Laitinen, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Kinase Plasticity in Response to Vandetanib Enhances Sensitivity to Tamoxifen in Estrogen Receptor Positive Breast CancerRasha T Kakati, Austin A Whitman, Santiago Haase, et al.
The American Journal of Managed Care|November 20, 2018
The use of betrixaban for extended prophylaxis of venous thromboembolism events in hospitalized, high-risk patientsPaul P Dobesh, Tania Ahuja, George A Davis, et al.
Pageof 18

Showing results (101-110 of 171) with videos related to

Sort By:
Pageof 18
Chemmedchem|April 11, 2022
Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor ChemotypeChristopher R M Asquith, Louisa Temme, Michael P East, et al.
Molecular & Cellular Proteomics : MCP|February 22, 2014
An unbiased proteomic screen reveals caspase cleavage is positively and negatively regulated by substrate phosphorylationJacob P Turowec, Stephanie A Zukowski, James D R Knight, et al.
Frontiers in Oncology|June 10, 2024
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of <i>PTEN</i>-null, <i>BRAFV600E</i> melanoma to BRAF/MEK inhibitionEvan DuBose, Samantha M Bevill, Dana K Mitchell, et al.
Cell Reports|March 9, 2017
MAP3K4 Controls the Chromatin Modifier HDAC6 during Trophoblast Stem Cell Epithelial-to-Mesenchymal TransitionRobert J Mobley, Deepthi Raghu, Lauren D Duke, et al.
British Journal of Pharmacology|October 5, 2017
Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysisBrian C Jensen, Traci L Parry, Wei Huang, et al.
The Biochemical Journal|November 21, 2007
Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complexHeidi Mendoza, David G Campbell, Kerry Burness, et al.
Journal of Medicinal Chemistry|April 12, 2019
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in ChordomaChristopher R M Asquith, Kaleb M Naegeli, Michael P East, et al.
Molecules (Basel, Switzerland)|October 13, 2021
Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid TumorsAndreas S Kalogirou, Michael P East, Tuomo Laitinen, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Kinase Plasticity in Response to Vandetanib Enhances Sensitivity to Tamoxifen in Estrogen Receptor Positive Breast CancerRasha T Kakati, Austin A Whitman, Santiago Haase, et al.
The American Journal of Managed Care|November 20, 2018
The use of betrixaban for extended prophylaxis of venous thromboembolism events in hospitalized, high-risk patientsPaul P Dobesh, Tania Ahuja, George A Davis, et al.
Pageof 18